Bristol-Myers SquibbBMY
NYSEPharmaceuticals
$57.46+0.63%
No cached AI snapshot yet for BMY.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
$121.26BMarket cap
$62.8952-week high
$42.5252-week low
11,682,050Avg volume (30d)
32,500 employees2.04B shares outstandingdividend yield 4.33%
Next earnings ~May 5, 2026 · Ex-dividend Apr 2, 2026 · Dividend $0.63 quarterly
About Bristol-Myers Squibb
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Latest News
Bristol-Myers Squibb in charts: Q1 revenue from Eliquis, Yervoy, and Orencia rises Y/Y; Sprycel, Opdivo, and Pomalyst/Imnovid falls
Bristol-Myers posts Q1 beat thanks to growth portfolio
Bristol-Myers Squibb Company Non-GAAP EPS of $1.58 beats by $0.16, revenue of $11.5B beats by $580M
Bristol-Myers Squibb Q1 Preview: Growth portfolio's performance in focus
Form DEF 14A Bristol-Myers Squibb For: 28 April
Whitbread plc 2026 Q4 - Results - Earnings Call Presentation
Related Stocksin Pharmaceuticals
Ready to see the live AI view on BMY?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing BMY side-by-side with live signals.